Fall 2020

NOVEMBER 16-17, 2020

Hosted By The Temple Lung Center,
Planned In Collaboration With
Global Initiative For Chronic Obstructive Lung Disease (GOLD) and
Global Initiative For Asthma (GINA)

NOVEMBER 16-17, 2020
9:00 AM–5:00 PM EST

View Downloadable Pre-Recorded Sessions
Followed by Live Moderated Q&A

This two-day virtual conference will combine live expert moderators with on-demand content, featuring the most recent GOLD and GINA strategies in the diagnosis, management, and treatment of patients with COPD and asthma.

Additional new educational material will include imaging overview, implementation models for primary care, and spirometry guidance.

Accredited educational material will be presented in an interactive format applicable to all healthcare providers associated with the care of patients burdened by these diseases.

Up to 11.5 hours of accredited continuing education.

Register today


more >

PERT Transforms Pulmonary Embolism Care and Practice

Pulmonary embolism (PE) is the third most common cardiovascular cause of inpatient hospital death in the United States, and the prevalence of PE risk factors—including surgery, obesity, a sedentary or immobile lifestyle, and advanced age—is increasing. Immobile lifestyle is a big concern in the COVID-19 era, where home isolation and social distancing are highly recommended. Continue Reading >

Case Study: Elevated Hemidiaphragm

A 60-year-old man with multiple co-morbidities presented for evaluation of dyspnea. Symptoms were slow and progressive, and he now struggled to swim or tie his shoelaces. A left- and right-heart catheterization was performed prior to presentation due to his history of nonischemic cardiomyopathy and were without coronary disease or pulmonary hypertension; his blood pressure and volume status were well controlled. Continue Reading >

New Treatment Pathways for Persistent Pulmonary Hypertension of the Newborn

Persistent pulmonary hypertension of the newborn (PPHN, also known as neonatal pulmonary hypertension and persistent fetal circulation syndrome), affects 2% of live births and is a major cause of neonatal mortality. PPHN is a failure to properly transition from placental respiration to breathing with the lungs; the pulmonary vasculature remains resistant to blood flow, leading to right-toleft shunting of blood across the ductus arteriosus or foramen ovale and causing often-severe hypoxemia. Continue Reading >

Role of Chest Imaging in Bronchoscopic Lung Volume Reduction Using Endobronchial Valves

Chronic obstructive pulmonary disease (COPD) is one of the leading causes of mortality and morbidity worldwide. The National Emphysema Treatment Trial (NETT) demonstrated that lung volume reduction surgery can improve pulmonary function, exercise capacity, and quality of life in selected subgroups of COPD patients, yet not all patients are good candidates for surgery. Clinical trials of bronchoscopic lung volume reduction (BLVR) procedures have sought to establish an effective and safe alternative approach for those patients. Continue Reading >